Only a limited number of cases have demonstrated concurrent JAK2 and MPL mutations, which have been associated with myelodysplastic/MPNs, polycythemia vera, and essential thrombocythemia [6–8, 10]. This evidence concerns the gene JAK2 and essential thrombocythemia.